We’re excited to bring you the latest edition of our European Women in VC x Morphais Spotlight. Each month, we will use this space to highlight outstanding startups across Europe led or co-led by inspiring women. These founders and leaders are driving innovation across sectors. This is not about numbers or gaps. It’s about celebrating the women building, leading, and scaling ventures that will shape our future. 🚀
Because the next wave of venture growth it’s being written in labs, greenhouses, clinical trials, and stealth-mode garages. Who is at the helm of many of these frontier ventures? Female founders who are blending scientific depth with commercial firepower.
Together with Morphais, we bring founders who are redesigning entire markets:
Making agriculture resilient to climate shocks.
Reimagining therapies for some of the deadliest cancers.
Engineering enzymes that could redefine industrial biotech.
Quietly building the next climate and robotics ventures in stealth.
Meet female founders that are building the infrastructure of tomorrow:
🇩🇪 Finches
#B2B #AI #AgTech #SupplyChainAgriculture is one of the sectors most exposed to climate volatility. Supply chains break, costs rise, and farmers face rising uncertainty. Finches leverages data and AI to provide climate-smart procurement solutions for agriculture, offering real-time risk insights and mitigation strategies.
👩🏼🌾👩🏻🎓 The founders:
Female power duo Catharina van Delden and Stefanie Glenn bring deep expertise, including a PhD in Developmental Genetics from top university (Cambridge). Former co-founder of software company Innosabi. Previous experience at multiple top companies, including as Head of Customer Engineering Germany (ex-Google), Forward Deployed Engineer (ex-Palantir Technologies) and Member of the Advisory and Supervisory Board (Deutsche Bank, Sto SE, EQT Group).
💡 Investor lens: A highly experienced team with proven exits and board-level credibility - rare in AgTech. Their positioning in climate-smart supply chains places them in a growing intersection of ESG-driven procurement and data-driven farming.
🇩🇪 Blueprint Biomed
#B2B #BioTech #HealthTechWith Europe’s aging population and rising accident-related injuries, demand for bone regeneration therapies is set to climb. Blueprint Biomed develops innovative solutions for bone regeneration, focusing on complex fractures and defects.
👩🏽🕵🏽🧑🏽💻 The founders:
Diverse founding trio Janina Stadter, Aarón Yerach Herrera Martin, Felix Lorenz with strong academic backgrounds in Business, Medicine, and Biochemistry from top university (TU Berlin), including a PhD in Philosophy. Previously co-founded Penta Trading, a rule-based portfolio management system. Professional experience at top companies as Senior Associate (ex-PwC) and Project Manager (ex-Charité).
💡 Investor lens: Rare combination of scientific depth + commercial experience. Positioned at the frontier of regenerative medicine, a subsector attracting sustained venture and public funding.
🇬🇧 Immobilase
#B2B #Platform #BioTech #IndustrialTechEnzymes are the hidden engines of industries, from pharmaceuticals to food. Immobilase specializes in developing rapid, reliable, and customizable enzyme products using advanced immobilization technology, transforming industrial bioprocessing.
👩🏽🔬 The founder:
Female founder Amy Locks with a PhD in Pharmaceutical Sciences from top university (UCL). Experience as Postgraduate Teaching Assistant, Software Developer and Visiting Researcher at top company (ex-Astra Zeneca). Currently part of the venture programs Cohort X and Fifty Years.
💡 Investor lens: Positioned at the intersection of industrial biotech and platform technology, a field expected to play a defining role in Europe’s green transition.
🇬🇧 Stealth Founder, Emily Tench
#FounderExperience, #FemaleFounder, #TopUniversity
With backgrounds at Harvard, Stanford, and co-founding a direct air capture venture, Emily Tench exemplifies the new wave of climate-tech operators turning stealth mode into long-term disruption.
👩🏽💻 The founder:
From Harvard Kennedy School to teaching and venture associate roles, Emily combines policy, academia, and startup building.
💡 Ecosystem note: Expect her next chapter to bridge climate innovation, policy, and commercialization.
🇩🇪 GliTTher
#B2B #Genetics #Platform #BioTech #HealthTech
Glioblastoma remains one of the deadliest cancers. GliTTher develops personalized therapies for glioblastoma by targeting glioma-initiating cells using a drug screening platform and lead compounds, that could radically improve treatment outcomes.
🕵️♀️👨🏽🔬🙋🏽♂️ The founders:
Virginie Clement-Schatlo, Sammy Mahdi, and Alexander Berg form a diverse founding team with strong academic backgrounds from top universities (University of Manchester, University of Cambridge, University of Geneva). The team includes two PhDs in Human Genetics and Sensor Technologies. Prior experience includes co-founding WaterScope, a deep-tech startup spun out of the University of Cambridge.
💡 Investor lens: Strong founding mix with both deep-science credibility and entrepreneurial track record. Positioned in an area where breakthrough therapies could unlock transformational patient outcomes and outsized returns.
🇨🇭 Stealth Founder, Camilla Mazzoleni
#TopCompanyAlumni #FemaleFounder #TopUniversity
With roots in robotics and AI, Camilla represents the wave of technical founders emerging from Europe’s top universities and ecosystem hubs.
👩🏽💻 The founder:
Computer Engineering + Robotics (Bergamo, ETH Zürich). Active in ETH Entrepreneur Club and Founderful Campus, networks that have become pipelines for Europe’s standout founders.
💡 Ecosystem note: Currently in stealth since July 2025, one to watch as ETH continues to generate Europe’s next unicorn builders.
That’s all for this month’s spotlight. At European Women in VC x Morphais, we believe in amplifying the talent and vision of women shaping Europe’s innovation.
💡 Stay tuned — we’ll be back mid-next month with another round of female founders to watch.
👉 If you’d like to nominate a founder for the spotlight, reach out!
As European Women in VC, we’ll keep spotlighting founders who show us where capital, policy, and partnerships must go next. With Europe already trailing the US, we simply can’t afford to leave half the talent pool untapped. Together with Morphais, we’re here to make sure these founders, and the markets they’re reshaping, are impossible to overlook.
About our Partner
Morphais - Data intelligence company, empower venture funds, corporates, tech companies, family offices, and other investment professionals in finding and accessing relevant (pre-) seed startups and founders as early as possible.Through their platform, they maximize the sourcing options for venture firms, ensuring they see a wide range of potential startups deals and connect them with top-notch founders.
Morphais long-term vision is to serve as the ultimate bridge between capital and entrepreneurs. In this way, they aim to diversify the startup landscape and ensure that brilliant ideas and diverse teams get the visibility and funding they deserve.
We're a squad of over 1000 senior female venture capital wizards from all over Europe and beyond. We're here to flip the script and make things right.
Join us in shaking up the VC world! 🚀
Take care!European Women in VCFollow us on LinkedIn